KATHRYN STRINGER: Open Payments
NPI 1912056755 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 13 payments from 8 companies in 2025. Trend: 2023 $306 · 2024 $84 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $69 |
| Astellas Pharma US Inc | 2 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Biogen, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
| Organon LLC | 1 | $18 |
| PFIZER INC. | 1 | $15 |
Products named: MYFEMBREE, Veozah, Lynkuet, ZURZUVAE, GARDASIL 9, LO LOESTRIN FE, NEXPLANON, ABRYSVO.
Industry payments across OR — which companies pay providers there.
